Encompass Health Co. (NYSE:EHC) is Oberweis Asset Management Inc.'s 6th Largest Position

Oberweis Asset Management Inc. increased its stake in Encompass Health Co. (NYSE:EHC - Free Report) by 11.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 340,829 shares of the company's stock after purchasing an additional 34,221 shares during the quarter. Encompass Health makes up approximately 1.5% of Oberweis Asset Management Inc.'s portfolio, making the stock its 6th biggest holding. Oberweis Asset Management Inc. owned 0.34% of Encompass Health worth $31,476,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in EHC. MassMutual Private Wealth & Trust FSB lifted its position in shares of Encompass Health by 87.8% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock worth $27,000 after acquiring an additional 137 shares in the last quarter. Transce3nd LLC purchased a new position in Encompass Health during the fourth quarter valued at approximately $40,000. CBIZ Investment Advisory Services LLC increased its holdings in Encompass Health by 38.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock worth $42,000 after acquiring an additional 127 shares during the period. Tompkins Financial Corp purchased a new stake in Encompass Health in the 4th quarter worth approximately $46,000. Finally, V Square Quantitative Management LLC boosted its holdings in Encompass Health by 43.8% in the 4th quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock valued at $54,000 after purchasing an additional 177 shares during the period. Institutional investors own 97.25% of the company's stock.

Analysts Set New Price Targets

EHC has been the subject of a number of research analyst reports. Royal Bank of Canada lifted their price target on Encompass Health from $110.00 to $125.00 and gave the company an "outperform" rating in a research report on Monday. UBS Group lifted their target price on shares of Encompass Health from $117.00 to $130.00 and gave the company a "buy" rating in a research report on Monday. William Blair reissued an "outperform" rating on shares of Encompass Health in a report on Friday, February 7th. Truist Financial reiterated a "buy" rating and issued a $135.00 target price (up from $116.00) on shares of Encompass Health in a research report on Monday. Finally, KeyCorp raised their price target on Encompass Health from $120.00 to $122.00 and gave the company an "overweight" rating in a research report on Friday. Nine equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, Encompass Health currently has an average rating of "Buy" and a consensus target price of $120.86.

Insiders Place Their Bets

In other news, CAO Andrew L. Price sold 5,042 shares of the business's stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total transaction of $495,578.18. Following the transaction, the chief accounting officer now owns 69,164 shares of the company's stock, valued at approximately $6,798,129.56. The trade was a 6.79 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 2.10% of the company's stock.

Encompass Health Stock Performance

Shares of EHC stock traded up $1.81 on Tuesday, reaching $117.13. The stock had a trading volume of 530,731 shares, compared to its average volume of 677,431. The stock has a market cap of $11.80 billion, a P/E ratio of 26.26, a price-to-earnings-growth ratio of 2.31 and a beta of 0.87. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05. Encompass Health Co. has a 1 year low of $82.38 and a 1 year high of $117.16. The company has a 50 day simple moving average of $100.35 and a 200 day simple moving average of $98.71.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings data on Thursday, April 24th. The company reported $1.37 EPS for the quarter, topping the consensus estimate of $1.19 by $0.18. The firm had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.43 billion. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. Encompass Health's revenue was up 10.6% on a year-over-year basis. During the same period in the prior year, the business posted $1.12 EPS. Equities research analysts expect that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st were given a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 0.58%. The ex-dividend date of this dividend was Tuesday, April 1st. Encompass Health's payout ratio is currently 14.05%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.